(Q42551626)

2 November 2017

title

Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain (English)

1 reference

2 November 2017

R M Parker

1

1 reference

2 November 2017

J M Barnes

2

1 reference

2 November 2017

J Ge

3

1 reference

2 November 2017

P C Barber

4

1 reference

2 November 2017

N M Barnes

5

1 reference

2 November 2017

publication date

1 December 1996

1 reference

Journal of the Neurological Sciences

2 November 2017

published in

1 reference

2 November 2017

volume

144

1 reference

2 November 2017

issue

1-2

1 reference

2 November 2017

page(s)

119-127

1 reference

Serotonin 5-HT3 receptors in schizophrenia: a postmortem study of the amygdala

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Pharmacological and regional characterization of [3H]LY278584 binding sites in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Neuropharmacology of emesis induced by anti-cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Identification of 5-HT3 recognition sites in the ferret area postrema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Normal densities of 5-HT3 receptor recognition sites in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Distribution and characterization of the [3H]granisetron-labelled 5-HT3 receptor in the human forebrain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Localization of 5-HT3 receptors in the rat brain using [3H]LY278584.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Ondansetron in carcinoid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

The distribution of 5-HT3 recognition sites in the marmoset brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

The distribution of specific binding of the 5-HT3 receptor ligand [3H]GR65630 in rat brain using quantitative autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Inter-species variants of the 5-HT3 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Inhibitory influence via 5-HT3 receptors on the induction of LTP in mossy fiber-CA3 system of guinea-pig hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Evidence that the 5-HT3 receptors of the rat, mouse and guinea-pig superior cervical ganglion may be different

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Autoradiography of [3H]quipazine in rodent brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Localization of 5-HT3 receptor binding sites in human dorsal vagal complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

5-HT3 antagonists in postoperative nausea and vomiting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Reduced levels of 5-HT3 receptor recognition sites in the putamen of patients with Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Organisation of the murine 5-HT3 receptor gene and assignment to human chromosome 11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

5-hydroxytryptamine3 receptors in the human brain: autoradiographic visualization using [3H]ICS 205-930.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900211-0

10.1016/S0022-510X(96)00211-0

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference